Table 1

ORs for histocytological confirmation and anticancer treatment

	Histocytological confirmation			Anticancer treatment
	OR^*	95% CI	p Value	OR^*	95% CI	p Value
Male	1	–	–	1	–	–
Female	0.81	0.77 to 0.86	<0.001	0.91	0.86 to 0.96	0.002
Age (years)
<40	0.85	0.55 to 1.31	0.451	1.10	0.70 to 1.72	0.671
40–49	1.40	1.12 to 1.76	0.004	1.97	1.57 to 2.47	<0.001
50–59	1.34	1.19 to 1.52	<0.001	1.40	1.25 to 1.58	<0.001
60–69	1	–	–	1	–	–
70–79	0.71	0.65 to 0.76	<0.001	0.59	0.55 to 0.63	<0.001
80–89	0.36	0.33 to 0.39	<0.001	0.24	0.22 to 0.26	<0.001
>90	0.12	0.10 to 0.15	<0.001	0.07	0.05 to 0.10	<0.001
Cancer stage
IA	1	–	–	1	–	–
IB	1.47	1.23 to 1.75	<0.001	1.29	1.07 to 1.56	0.007
IIA	1.07	0.72 to 1.58	0.735	0.99	0.65 to 1.49	0.946
IIB	1.65	1.34 to 2.02	<0.001	1.06	0.86 to 1.30	0.585
IIIA	1.66	1.40 to 1.98	<0.001	1.01	0.85 to 1.22	0.876
IIIB	1.92	1.65 to 2.25	<0.001	0.85	0.72 to 1.00	0.049
IV	1.38	1.20 to 1.59	<0.001	0.59	0.51 to 0.68	<0.001
Unknown	0.87	0.75 to 1.00	0.055	0.52	0.44 to 0.60	<0.001
Performance status
0	1	–	–	1	–	–
1	0.93	0.83 to 1.04	0.205	0.84	0.76 to 0.94	0.002
2	0.47	0.42 to 0.53	<0.001	0.34	0.30 to 0.38	<0.001
3	0.20	0.18 to 0.23	<0.001	0.10	0.09 to 0.11	<0.001
4	0.10	0.09 to 0.12	<0.001	0.03	0.02 to 0.04	<0.001
Unknown	0.43	0.38 to 0.48	<0.001	0.31	0.28 to 0.34	<0.001
Diagnosed comorbidity	0.75	0.69 to 0.82	<0.001	0.75	0.69 to 0.82	<0.001
Histocytologically confirmed	–	–	–	4.02	3.75 to 4.30	<0.001